3rd International Conference On Drug Discovery and Development: 4th Dimension ERA (IC3D4D – 2026)

BEYOND THE BENCH:
TRANSLATING DRUG RESEARCH INTO THERAPEUTIC PRODUCTS
8th–10th JULY 2026

Jointly Organized by

Centre for Active Pharmaceutical Ingredients

Faculty of Pharmacy

Register Now

About the Institution

Karpagam Academy of Higher Education (KAHE), a premier Deemed-to-be University, is committed to holistic learning and research excellence. The institution encompasses five faculties: Arts, Science, Commerce & Management; Engineering; Architecture, Design & Planning; Pharmacy; and Performing Arts. It also hosts 13 specialized research centers that drive innovation, interdisciplinary collaboration, and pioneering research. KAHE has consistently been recognized for its academic and research achievements, securing a position in the 101-150 rank band in the NIRF University Rankings. On the global front, it is ranked in the Times Higher Education 2025 Interdisciplinary Subject Rankings (401-500) and the Impact Rankings (401-600). With a strong research profile of over 7,500 publications, 70,000 citations, an institutional h-index of 96, and 147 granted patents, KAHE continues to expand knowledge, strengthen international collaborations, and affirm its position as a leading institution in higher education.

About the Conference

In the 4th -dimension era of drug discovery and development, innovation extends far beyond the laboratory bench. Volume 3 of this international conference focuses on the critical journey of translating cutting-edge research into safe, effective, and market-ready therapeutic products. Emphasizing integration of artificial intelligence, advanced analytics, digital platforms, and translational sciences, this volume brings together academia, industry, and regulatory stakeholders to accelerate the transformation of scientific discoveries into real-world healthcare solutions. The conference on drug discovery and development serves as a crucial platform for students, faculties, researchers, and industry professionals to converge and share the latest advancements, challenges, and breakthroughs in the field.

About the Centre For Active Pharmaceutical Ingredients

The Centre for Active Pharmaceutical Ingredients (CAPI) is committed to excellence in pharmaceutical development. The primary focus lies on Process development and the synthesis of off-patent Active Pharmaceutical Ingredients (APIs), including kilo-scale API production. The Centre is also actively involved in drug discovery, particularly in the design and synthesis of small molecules targeting tuberculosis, antimicrobial resistance, viral infections, and cancer. CAPI maintains collaborations with various academic institutions and industries both in India and abroad.

About the Faculty of Pharmacy

The Faculty of Pharmacy was established in the year 2015 with B. Pharm degree course approved by Pharmacy Council of India (PCI), New Delhi, and has since been deeply rooted in classical pharmacy teaching and research. In 2019, Pharm. D Course was started and in the year 2020, M. Pharm program initiated with the specializations of Pharmaceutical Analysis and extended with Pharmaceutics and Pharmaceutical Chemistry in 2022. Additionally, the Faculty of Pharmacy offers both full-time and part-time Ph.D. programs. The discipline covers a broad range of teaching and research areas from pharmacokinetics, drug-receptor theory, molecular and cellular mechanisms of drug actions, disease-specific systems of pharmacy, drug modality development, pharmacogenetics, personalized medicine, drug development, clinical drug trial, adverse drug reactions and toxicology. FOP has a strong team of academic and research staff committed to excel in the pharmacy education and research missions. Faculty of Pharmacy has collaborations with leading universities in countries, including Malaysia, Vietnam, and Philippines.

Conference Committee

Organizing Committee

CHIEF PATRON

Dr. R. VASANTHAKUMAR

President,
Karpagam Academy of Higher Education.

PATRONS

Shri. K. MURUGAIAH

Chief Executive Officer,
Karpagam Educational Institutions.

Prof. S. RAVI

Vice Chancellor,
KAHE.

Prof. B. V. PRADEEP

Registrar,
KAHE.

Prof. V. PARTHASARATHY

Dean – R&D and Industry Relations,
KAHE.

Prof. D. KUMUDHA

Dean,
Faculty of Pharmacy, KAHE.

CONVENER

Prof. P. SENTHIL KUMAR

Head, Centre for Active Pharmaceutical Ingredients,
KAHE.

Prof. B. RAJKAPOOR

Head, Department of Pharmacology,
Faculty of Pharmacy, KAHE.

ORGANIZING SECRETARIES

Prof. T. DEVADOSS

Head, Department of Pharmaceutical Chemistry,
Faculty of Pharmacy, KAHE.

Prof. R. HARIPRASAD

Head, Department of Pharmaceutical Analysis,
Faculty of Pharmacy, KAHE.

Dr. V. V. SATHIBABU UDDANDRAO

Assistant Professor,
Centre for Active Pharmaceutical Ingredients, KAHE.

International Conference 2026

REGISTRATION

Delegates Early Bird Registration Spot Registration
Students Rs. 2000 Rs. 2250
Research Scholar / Faculty / Industrialists Rs. 2250 Rs. 2500
Foreign Delegates USD. 100 USD. 120

Scan & Register

QR Code

Call for Abstract

Delegates are cordially invited for presentations in the field of pharmaceutical sciences. IC3D4D – 2026 invites the authors to present their research findings in oral or poster presentation. The selected presentation will be given a chance to present on stage in front of the audience.

  • E-mail: 3d4dconference@kahedu.edu.in
  • The title of the abstract should be in bold with font size of 14.
  • Authors & co-authors details with affiliation should be provided (font size 10).
  • The abstract must not exceed the word limit of 250 words (font size12).
  • The entire abstract should be prepared with Times New Roman font style.
  • E-mail id of author and presenter should be mentioned.
  • Last date for Abstract submission: 30/06/2026.

Address for Communication

The Convener,
International Conference on “Drug Discovery and Development: 4th Dimension Era” (IC3D4D – 2026)

Karpagam Academy of Higher Education,
Coimbatore-641021, Tamil Nadu, India.
Email: 3d4dconference@kahedu.edu.in
Phone: +91-8489057776

CONFERENCE SPEAKERS

Dr. SVEN MARCEL STEFAN

Medical University of Lublin,
Poland.

Dr. KATJA STEFAN

University of LĂĽbeck, University Medical Center Schleswig-Holstein,
Germany.

Dr. VIGNESHWARAN NAMASIVAYAM

Venture-backed Biotech Companies,
LĂĽbeck Institute of Experimental Dermatology (LIED),
University Medical Center Schleswig-Holstein (UKSH),
University of LĂĽbeck (UzL), Germany.

Dr. PERMAIYAN RAJENDRAN

King Faisal University,
Al Ahsa, Saudi Arabia.

Dr. PALANISAMY AMIRTHALINGAM

University of Tabuk,
Tabuk, Kingdom of Saudi Arabia.

Prof. D. SRIRAM

BITS Pilani, Hyderabad Campus
Hyderabad, India.

Dr. U.P. SENTHILKUMAR

3xper Innoventure Limited,
Chennai, India.

Dr. SANKARGANESH JEYARAJ

Center for Molecular Medicine & Therapeutics, PSG IMSR and Hospitals,
Coimbatore, India.

Dr. N. THAMIZH SELVAM

National Ayurveda Research Institute for Panchkarma, Ministry of Ayush, Govt. of India,
Thrissur, India.